Managed Problem Solving for Antiretroviral Therapy Adherence
Authors:
Open Access
- 25 February 2013
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 173 (4) , 300-306
Abstract
Adherence to pharmacotherapy is key to preventing progression of treatable chronic diseases. Unfortunately, clinically significant nonadherence is common in diabetes mellitus,1 hypertension,2 hypercholesterolemia,3 and human immunodeficiency virus (HIV),4 for example. Adherence barriers include depression,5 substance abuse,6 regimen complexity,7 poor social support,8 and low health literacy,9,10 among others. Adherence interventions have had limited effects, which often wane over subsequent months.11-13Keywords
This publication has 36 references indexed in Scilit:
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011
- A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed peopleAIDS, 2010
- Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trialThe Lancet, 2010
- Risk Factors for Medication Non-Adherence in an HIV Infected Population in the Dominican RepublicAIDS and Behavior, 2010
- Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trialsThe Lancet, 2009
- Modified Directly Observed Antiretroviral Therapy Compared With Self-administered Therapy in Treatment-Naïve HIV-1–Infected PatientsArchives of internal medicine (1960), 2009
- Superiority of Directly Administered Antiretroviral Therapy over Self-Administered Therapy among HIV-Infected Drug Users: A Prospective, Randomized, Controlled TrialClinical Infectious Diseases, 2007
- Medication Beliefs as Mediators of the Health Literacy–Antiretroviral Adherence Relationship in HIV-infected IndividualsAIDS and Behavior, 2006
- Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitnessAIDS, 2006
- An overview of methods for the analysis of longitudinal dataStatistics in Medicine, 1992